Arax Advisory Partners’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$111K Buy
38,424
+37,841
+6,491% +$96.2K ﹤0.01% 2655
2026
Q1
$1.14K Buy
583
+523
+872% +$1.23K ﹤0.01% 3258
2025
Q4
$163 Sell
60
-332
-85% -$1.09K ﹤0.01% 3753
2025
Q3
$1.66K Buy
+392
New +$1.72K ﹤0.01% 3156
2024
Q4
Sell
-117
Closed -$812 2542
2024
Q3
$812 Hold
117
﹤0.01% 2318
2024
Q2
$913 Buy
+117
New +$867 ﹤0.01% 2197

Other funds holding GDRX

Arax Advisory Partners's GDRX Position: Q2 2026 in Review

Arax Advisory Partners increased its GoodRx Holdings (GDRX) stake by 6,491% in Q2 2026, buying an estimated $96.2K and bringing the position to 38,424 shares worth $111K. The position accounts for ﹤0.01% of the portfolio, ranked #2655.

Arax Advisory Partners first reported a position in GDRX in Q2 2024 and has held it in 6 quarters since. 162 funds tracked by Wall St. Rank hold GDRX as of Q2 2026.

  • Arax Advisory Partners held 38,424 shares of GoodRx Holdings worth $111K as of Q2 2026.
  • Arax Advisory Partners bought 37,841 GoodRx Holdings shares in Q2 2026, an estimated $96.2K.
  • GoodRx Holdings made up ﹤0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #2655 holding.
  • Arax Advisory Partners first reported a position in GoodRx Holdings in Q2 2024 and has held it in 6 quarters since.
  • 162 funds tracked by Wall St. Rank held GoodRx Holdings as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.